MarketInOut Stock Screener Log In | Sign Up
 

Co-Diagnostics Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Co-Diagnostics Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.98 mln
Float6.98 mln
Earnings Date11/05/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-9.11
Highly reliable

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.14
Very low leverage

Pre-Tax Margin

-9,413%
Severely loss-making

ROE

-180
Deeply negative

Business Description

Co-Diagnostics is a Salt Lake City-based company that creates and sells testing technology used to detect infectious diseases and other health conditions at the genetic level. Their products cover a wide range of illnesses, including COVID-19, influenza, tuberculosis, hepatitis, and several mosquito-borne diseases, and can be used both in clinical settings and at home. Beyond human health, the company also develops tools for cancer screening and agricultural testing, helping identify specific genetic traits in plants and animals.

Key Fundamentals

EPS-26.14
ROE-180
RPS0.30
ROIC-141
ROA-150
EBITDA, mln-47.69
EV / EBITDA-0.08
EV / EBIT-0.08
Revenue, mln0.52
EV / Revenue7.79

Quote Details

Last 0.5455
Change -0.0245 (-4.3%)
Open 0.555
Volume 282,671
Turnover 154,197
Average Volume 381,941

Financial Ratios

Pre-Tax Profit Margin-9,413
Leverage Ratio1.31
Current Ratio1.81
Price / Book0.41
Price / Tangible Book0.95
Debt / Equity0.14
Price / Sales4.33

Financial Strength

Altman Z-Score-16.38
Piotroski F-Score 3 / 9
Beneish M-Score-9.11
Short Ratio1.73
Short % of Float6.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.59% 4 / 100   
1 Month -52.57% 4 / 100   
2 Months -77.64% 2 / 100   
6 Months -67.34% 7 / 100   
1 Year -95.21% 3 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog